PRAL (P53 regulation associated lncRNA) is downregulated in HCC, lung cancer and MM, and GAS5 (growth arrest specific 5) in breast, prostate, renal cancer and MM [43,86,87,101,102]. Here, GAS5 is linked to renal carcinoma.